GWBU is the Stock to Watch!
May 14th, 2012 | 
Author: Why Invest in Start Technologies Europe I.G. (GWBU)?
History shows that early investment in successful innovation companies is a path to enormous financial rewards.
Imagine if you had been among the first investors in Microsoft, Apple, Amazon or Google.
Start Technologies Europe I.G., publicly trading under the ticker symbol (GWBU), is an innovation pioneer in an emerging technology sector that addresses two of society’s most pressing concerns: energy efficiency and air quality.
Here is your chance to take an early position in a ground-breaking technology that is being made available to the public for the first time.
Product Highlights
Start significantly reduces emissions and increases fuel economy in closed combustion engines.
How it works:
Start discharges a high-voltage electric current into liquid gas or diesel at ambient temperature as it flows through the engine fuel line prior to entering the engine combustion chamber.
The electric current, applied at a proprietary frequency and wavelength, cracks the longer-chain hydrocarbon molecules into shorter, lighter more volatile molecules, which burn more readily and completely in the combustion chamber.
Combustion efficiency increases in shorter-chain hydrocarbon molecules because more of the molecule’s surface is exposed to oxygen, which is necessary for combustion to occur.
And the more completely fuel combusts, the lower the emission output and the better the gas mileage.
Start also removes carbon deposits, a key barrier to complete fuel combustion and one that is endemic to older-model engines.
May 10th, 2012
BOLOGNA, ITALY–(Marketwire – May 9, 2012) – Great Wall Builders, Ltd. (OTCBB:GWBU) (“Great Wall” or the “Company”) is pleased to announce that it will be conducting all business operations under the name Start Technologies Europe I.G., a wholly-owned subsidiary of the Company.
As previously announced, Great Wall recently acquired all the assets of dPollution International, Inc. which owned the intellectual property, manufacturing rights, and marketing rights to the Start Fuel Efficiency and Emission Device (FEED) unit, an aftermarket device that improves the combustibility of gasoline or diesel fuels in internal combustion engines. The patent pending fuel-conditioning technology has been shown to reduce polluting emissions and increase engine efficiency/mileage. The Start FEED technology has reached the commercialization stage and the Company continues to test and demonstrate the device with potential clients around the world.
“We are very excited to have completed our corporate transformation and operating under the new Start Technologies Corp. banner will better reflect the direction that we are taking as a technology development company,” stated Mr. Daniele Brazzi, President and CEO of Great Wall. “In the coming months, as we move forward with our business plan to commercialize the Start FEED technology, we also intend to intensify our marketing and public relations efforts to raise awareness of our company and patent pending technology within the global investment community. The entire team is eager to move forward with our growth strategy and intends to build the company for the long-term benefit of all our shareholders.”
Great Wall Builders, Ltd. – GWBU
Great Wall Builders, Ltd. (operating as “Start Technologies Europe I.G.”) owns the exclusive manufacturing and distribution rights to the Start Fuel Efficiency and Emission Device (FEED), an aftermarket device for internal combustion engines that enhances performance by causing fuel to combust more efficiently and completely. The technology uses a high-voltage electric current to break long-chain hydrocarbon molecules into shorter, lighter more volatile molecules. The patent-pending device produces a number of important benefits, including; lower emissions; reduced fuel consumption; and improved engine performance. The technology can be applied to a variety of different types of engines, both diesel and gasoline powered, heavy equipment as well as consumer vehicles. For more information, visit www.StartTechnologiesCorp.com.
Congratulations to our Members!
Our last three picks – BFLX – SNPK and GTRL – have shown almost 600% in profits!
We have a brand new, major pick coming soon! Don’t miss out!
Our latest pick, GTRL pulled back slightly yesterday but still held decent gains over our original alert. GTRL climbed to 102% profits over the last two days. BFLX gained 286%. SNPK gained 200% What a great start to the year! Our next major alert is coming soon and you do not want to miss it!
These days email delivery is often not the best way to get an urgent alert. Fighting the spam traps is a daily battle. Through our sister site, www.cellphonestocktips.com, we now offer our alerts over the SMS text messaging system. Never miss another major alert. Simply text the word ’stock’ to 46786 to sign up. The service is free but normal text charges may apply according to your individual text plan.
Happy Trading All!
The GIA Staff
Our last two alerts – BFLX and SNPK – have offered our Members 500% profits!
While our next major alert is still a few weeks away, we are constantly looking for opportunities for our Members to make a profit. This week that opportunity is GTRL.
GTRL closed at .068 Friday, a pull back from it’s all time high of .10. GTRL’s chart shows that over the last few months, each pull back is followed by a breakout – a pattern savvy investors look for. The run up to .10 showed over 100% gains and GTRL could easily post that again this week – and more. Social Net chatter is predicting 200% over Monday and Tuesday. Be aware that GTRL may move quickly so keep your eyes on it to maximize profits.
The Company:
Get Real USA, Inc. (GTRL) is engaged in the production of high quality genre films focused on lower cost utilizing highly recognizable talent. The Get Real management team is comprised of talented, well known executives and board members whose expertise spans decades in the industry. The Get Real team is relentless in carrying out their mission of protecting the company’s financial investments by focusing on reducing risk and maximizing profitability on every project. The agreement with LAMP is an example of utilizing the teams’ relationships in the industry to execute the company’s plan of business.
Latest Press:
Tierre Turner and Award Winning Actor, Director Michael Worth Team Up to Produce and Direct Upcoming Film “Blink” for Get Real USA
BEVERLY HILLS, Calif., Jan. 26, 2012 — Get Real USA, Inc. (PK:GTRL) announces that new Get Real USA team member Mr. Tierre Turner and director, writer and actor Mr. Michael Worth officially plan to work together to ensure the forth coming production of the movie “Blink” will be a success. The story line of the movie Blink will center around a sexy and very complex serial killer. The very well-known actress slotted to play this part will be announced very soon. Get Real President Mr. Khalil Kain will also have a major role in this action packed thriller. Other members of the cast will be announced via a formal corporate news release forth coming. The film will be shot on location in Connecticut and Louisiana. The company will be taking advantage of its agreement with Louisiana Media Productions (LAMP) and tax incentives offered in both location states.
Listen to an interview with Get Real USA, Inc. Chairman Aaron Johnson at: www.ceoinsidertv.com
Happy Trading Everyone!
We alerted our Members last Thursday at 2:45 in the afternoon when SNPK was trading at .28 – .32.
SNPK has broken through the .70’s and is on it’s way to $1.00
| Sunpeaks Ventures, Inc. Symbol: (SNPK) | |
| Sunpeaks Ventures, Inc (”Sunpeaks”), and wholly owned subsidiary Healthcare Distribution Specialists, LLC (”HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (”OTC”) branded multivitamins to the healthcare provider market. According to the Healthcare Distribution Management Association, about 85% of all prescription medications are sold through healthcare distributors in the United States, which amounts to $300 billion in revenue. Currently, HDS serves the secondary segment of the specialty drug market, estimated by management to be a $45 billion market segment. HDS currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers’ production shortages. In 2011 alone, there were over 200 drug shortages and by FDA estimates, this problem is only expected to worsen as more pharmaceuticals go generic. In addition to pharmaceuticals, HDS also distributes over-the-counter (”OTC”) branded health supplements. Sunpeaks is currently analyzing several OTC products that would allow us to become a powerful Over-The-Counter player in the multi-billon dollar health supplement market. | |
Breaking Company News: SILVER SPRING, Md., March 7, 2012 /PRNewswire/ — Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the “Company” or “Sunpeaks Ventures”) and its’ wholly owned subsidiary Healthcare Distribution Specialist, LLC (”HDS”) are pleased to provide this update regarding the development and market potential of Clotamin®, an OTC multivitamin product owned and marketed by the Company.
Clotamin® is the world’s first specialized OTC multivitamin product designed exclusively for use by patients on Warfarin® or other anticoagulants (blood thinners). According to BioMed Trends, in a report released by Global Industry Analysts, Inc., the global anticoagulants market is projected to surpass $11.2 billion by the year 2015, driven by an aging global population, rising incidence of cardiovascular diseases, cancers, and acute hip and knee complications, as well as emergence of innovative therapeutics targeting new and previously targeted clotting factors.
“The Warfarin market is absolutely enormous, – in fact, it’s one of the Top 20 most prescribed drugs in the United States, with over 32 million prescriptions being written each year for approximately 6 to 7 million patients,” stated Mackie A. Barch, CEO of Sunpeaks and longtime Warfarin patient. “By my calculations, if Sunpeaks is able to penetrate just 5% of the Warfarin market in just the U.S., sales for Clotamin could potentially surpass $25 million dollars annually. We look forward to ramping up our marketing and distribution efforts over the next few weeks and increasing awareness of Clotamin nationwide.”
More Company News:
SILVER SPRING, Md., March 7, 2012 /PRNewswire/ — Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the “Company” or “Sunpeaks Ventures”), value-added distributor of specialty drugs and over-the-counter (”OTC”) branded multivitamins to the healthcare provider market, is pleased to announce that it has forwarded all necessary documentation to the company’s transfer agent to cancel 50,000,000 common shares of the Company’s stock with the intent of improving the overall capital structure and to increase shareholder value. The cancelled shares were previously held by Mr. Mackie A. Barch, CEO of Sunpeaks.
The share cancellation reduces the total number of issued and outstanding shares from 420,500,750 to 370,500,750.
KEEP SNPK ON YOUR RADAR!
As promised, we’ve got an an amazing new pick. Over the next few days BFLX is going to be the hottest stock trading. We’ve heard rumors that profits of 1600% are possible and once you take a look at this exciting company you’ll see why!
Posted in 
Be The First To know
Any serious player knows that timing is everything. If you miss an early run you miss an opportunity to make money. If you miss a sell alert you’re losing money. Our job is to get you the information you need when you need it. Be a winner. Be the first to know. Sign up today.
